Why in news?
A major breakthrough in osteoarthritis research shows that inhibiting the protein 15‑PGDH can regenerate cartilage, reduce inflammation, and improve joint function—potentially offering a new treatment path beyond pain management or joint replacement
What the Research Found?
- Protein Target: Scientists identified 15‑PGDH (15‑hydroxy prostaglandin dehydrogenase) as a key driver of cartilage loss in aging joints.
- Mouse Studies: Blocking 15‑PGDH in aged and injured mice led to:
- Thicker knee cartilage (restoring lost tissue)
- Improved gait and mobility
- Reduced pain and inflammation
- Human Tissue Evidence: Samples from knee surgeries showed:
- Stiffer, healthier cartilage after treatment
- Lower inflammation markers
- Suggests regeneration without stem cells, a simpler therapeutic approach.
About Osteoarthritis
Osteoarthritis is the most common form of arthritis, caused by the gradual breakdown of cartilage in joints, leading to pain, stiffness, and reduced mobility. It primarily affects the knees, hips, hands, and spine, and while it cannot be reversed, symptoms can be managed through lifestyle changes, medications, and sometimes surgery.
Symptoms
- Joint pain and tenderness
- Stiffness, especially after inactivity
- Swelling and inflammation
- Loss of flexibility and reduced range of motion
- Grating or crackling sounds (crepitus) during movement
Causes & Risk Factors
- Causes:
- Cartilage wear and tear over years
- Previous joint injuries
- Abnormal joint development
- Genetic predisposition
- Risk Factors:
- Aging
- Obesity (extra stress on weight-bearing joints)
- Repetitive stress from certain jobs or sports
- Family history of arthritis
Treatment
- Pain relievers (acetaminophen, NSAIDs)
- Topical creams or gels
- Corticosteroid injections for severe pain
- Joint replacement surgery (hip/knee) in severe cases
- Assistive devices (braces, canes)
Download Pdf
